|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-4-6
|
|
pubmed:abstractText |
To elucidate the effects of blood ribavirin disposition on ribavirin-induced anemia, the relationship between erythrocyte ribavirin concentration and change in hematologic parameters was examined in interferon and ribavirin combination therapy for HCV eradication.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1542-3565
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
337-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15067629-Anemia,
pubmed-meshheading:15067629-Biological Availability,
pubmed-meshheading:15067629-Chromatography, High Pressure Liquid,
pubmed-meshheading:15067629-Dose-Response Relationship, Drug,
pubmed-meshheading:15067629-Drug Therapy, Combination,
pubmed-meshheading:15067629-Erythrocytes,
pubmed-meshheading:15067629-Female,
pubmed-meshheading:15067629-Follow-Up Studies,
pubmed-meshheading:15067629-Hepatitis C, Chronic,
pubmed-meshheading:15067629-Humans,
pubmed-meshheading:15067629-Interferon-alpha,
pubmed-meshheading:15067629-Male,
pubmed-meshheading:15067629-Prospective Studies,
pubmed-meshheading:15067629-Recombinant Proteins,
pubmed-meshheading:15067629-Ribavirin,
pubmed-meshheading:15067629-Risk Assessment,
pubmed-meshheading:15067629-Sampling Studies,
pubmed-meshheading:15067629-Severity of Illness Index
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Marked elevation of erythrocyte ribavirin levels in interferon and ribavirin-induced anemia.
|
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, University of Tsukuba, Ibaraki, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
